Merck pens $300M-per-product collab with Epitopea to locate 'hidden' tumor...

Published on 19 Feb 2025 on FierceBiotech

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to...

Read the rest of the article

Start tracking your investments with Statfolio

Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut shor...

Los Angeles Times 19 Feb 2025

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to...

FierceBiotech 19 Feb 2025

E Merck KG's board of partners has announced the appointment of new CEOs to Merck KGaA’s executiv...

Pharmaceutical Technology · via Yahoo Finance 19 Feb 2025

We recently compiled a list of the 13 Cheap High Dividend Stocks To Invest In Now. In this articl...

Insider Monkey · via Yahoo Finance 18 Feb 2025

On Tuesday, the European Commission (EC) conditionally approved Merck & Co Inc’s (NYSE:MRK) Welir...

Benzinga · via Yahoo Finance 18 Feb 2025

Merck (NSE:PROR) & Co., Inc. (NYSE: MRK), a global healthcare giant, finds itself at a critical...

Investing.com 18 Feb 2025

Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the...

Reuters · via Yahoo News 18 Feb 2025

We recently published a list of 10 Best Very Cheap Stocks To Buy Right Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Feb 2025

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going...

Insider Monkey · via Yahoo Finance 18 Feb 2025

We recently published a list of Top 10 Best Dividend Stocks on Robinhood. In this article, we are...

Insider Monkey · via Yahoo Finance 1 Feb 2025